American Shared Hospital Services (NYSE AMEX:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy solutions, will hold its quarterly conference call to discuss third quarter of 2011 results on Monday, November 14, 2011 at 3:00 p.m. Eastern Time/12:00 noon Pacific Time. Third quarter results of 2011 will be released the morning of Monday, November 14, 2011.
Monday, November 14, 2011 at 3:00 p.m. ET/12:00 noon PT
Teleconference and Webcast InformationTo participate, please call (800) 588-4973 at least 5 minutes prior to the start of the call. A live on-demand webcast of the call will be provided by Thomson Reuters and posted at www.ashs.com and www.earnings.com. The webcast is also being distributed over Thomson Reuters’ Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson Reuters’ individual investor center at www.earnings.com or by visiting any of the investor sites in Thomson Reuters’ Individual Investor Network. Institutional investors can access the call via Thomson Reuters’ password-protected event management site, StreetEvents ( www.streetevents.com). About AMS ( www.ashs.com ) American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the 21st Century® concept. Through its preferred stock investment in Mevion Medical Systems, Inc, AMS plans to complement these services with the Mevion S250 proton beam radiation therapy (PBRT) system, which has not yet been approved by the FDA.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts